［1］ Hausmann C D, Ibba M. AminoacyltRNA synthetase complexes: molecular multitasking revealed. FEMS Microbiol Rev,2008,32(4): 705~721 ［2］ Han J M, Kim J Y, Kim S. Molecular network and functional implications of macromolecular tRNA synthetase complex. Biochem Biophys Res Commun, 2003,303(4):985~993 ［3］ Greenberg Y, King M, Kiosses W B, et al. The novel fragment of tyrosyl tRNA synthetase, miniTyrRS, is secreted to induce an angiogenic response in endothelial cells. FASEB J, 2008,22(5):1597~1605 ［4］ Pohlmann J, BrtzOesterhelt H. New aminoacyltRNA synthetase inhibitors as antibacterial agents. Curr Drug Targets Infect Disord, 2004,4(4):261~272 ［5］ Kim S, Lee S W, Choi E C, et al. AminoacyltRNA synthetases and their inhibitors as a novel family of antibiotics. Appl Microbiol Biotechnol, 2003,61(4):278~288 ［6］ Mukai T, Kobayashi T, Hino N, et al. Adding llysine derivatives to the genetic code of mammalian cells with engineered pyrrolysyltRNA synthetases. Biochem Biophys Res Commun, 2008,371(4):818~822 ［7］ Kiga D, Sakamoto K, Kodama K, et al. An engineered Escherichia coli tyrosyltRNA synthetase for sitespecific incorporation of an unnatural amino acid into proteins in eukaryotic translation and its application in a wheat germ cellfree system. Proc Natl Acad Sci USA, 2002,99(15):9715~9720 ［8］ Kobayashi T, Sakamoto K, Takimura T, et al. Structural basis of nonnatural amino acid recognition by an engineered aminoacyltRNA synthetase for genetic code expansion. Proc Natl Acad Sci USA, 2005,102(5):1366~1371 ［9］ Ruan B, Sll D. The bacterial YbaK protein is a CystRNAPro and CystRNA Cys deacylase. J Biol Chem,2005,280 (27):25887~25891 ［10］ Bailly M, Blaise M, Lorber B, et al. The transamidosome: a dynamic ribonucleoprotein particle dedicated to prokaryotic tRNAdependent asparagine biosynthesis. Mol Cel ,2007,28(2):228~239 ［11］ PraetoriusIbba M, Rogers T E, Samson R, et al. Association between Archaeal prolyl and leucyltRNA synthetases enhances tRNA(Pro) aminoacylation. J Biol Chem, 2005,28 0(28):26099~26104 ［12］ Karanasios E, Simader H, Panayotou G, et al. Molecular determinants of the yeast Arc1paminoacyltRNA synthetase complex assembly. J Mol Biol,2007,374(4):1077~1090 ［13］ Guzzo C M, Yang D C. LysyltRNA synthetase interacts with EF1alpha, aspartyltRNA synthetase and p38 in vitro. Biochem Biophys Res Commun,2008,365(4):718~723 ［14］ 徐敏刚. 亮氨酰tRNA 合成酶和 tRNALeu的相互作用.上海:中国科学院上海生命科学研究院,2004. Xu M G. The interaction between leucyltRNA synthetase and tRNALeu. Shanghai: Shanghai Institutes for Biological Sciences,Chinese Academy of Science, 2004 ［15］ 刘云清. 大肠杆菌亮氨酰tRNA合成酶编校结构域和其与蛋氨酸和异亮氨酸复合物晶体结构的研究. 上海:中国科学院上海生命科学研究院,2006 Liu Y Q. The crystal structures of the editing domain of E. coli leucyltRNA synthetase and its complexes with methionine and isoleucine. Shanghai: Shanghai Institutes for Biological Sciences,Chinese Academy of Science, 2006 ［16］ Kowal A K, Kohrer C, RajBhandary U L. Twentyfirst aminoacyltRNA synthetasesuppressor tRNA pairs for possible use in sitespecific incorporation of amino acid analogues into proteins in eukaryotes and in eubacteria. Proc Natl Acad Sci USA, 2001,98(5):2268~2273 ［17］ Tang Y, Tirrell D A. Attenuation of the editing activity of the Escherichia coli leucyltRNA synthetase allows incorporation of novel amino acids into proteins in vivo. Biochemistry, 2002 ,41(34):10635~10645 ［18］ Kiick K L, Weberskirch R, Tirrell D A. Identification of an expanded set of translationally active methionine analogues in Escherichia coli. FEBS Lett, 2001,502(12):25~30 ［19］ Rock F L, Mao W, Yaremchuk A, et al. An antifungal agent inhibits an aminoacyltRNA synthetase by trapping tRNA in the editing site. Science,2007,316(5832):1759~1761 ［20］ Bernier S, Akochy P M, Lapointe J, et al. Synthesis and aminoacyltRNA synthetase inhibitory activity of aspartyl adenylate analogs. Bioorg Med Chem,2005,13(1):69~75 ［21］ Balg C, Blais S P, Bernier S, et al. Synthesis of betaketophosphonate analogs of glutamyl and glutaminyl adenylate, and selective inhibition of the corresponding bacterial aminoacyltRNA synthetases. Bioorg Med Chem, 2007,15(1):295~304 ［22］ Otani A, Slike B M, Dorrell M I, et al. A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc Natl Acad Sci USA,2002,99(1) : 178~183 ［23］ Tzima E, Schimmel P. Inhibition of tumor angiogenesis by a natural fragment of a tRNA synthetase. Trends Biochem Sci, 2006 ,31(1):7~10 ［24］ Edvardson S, Shaag A, Kolesnikova O, et al. Deleterious mutation in the mitochondrial arginyltransfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet, 2007,81(4): 857~862 ［25］ Scheper G C, van der Klok T, van Andel R J, et al. Mitochondrial aspartyltRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.Nat Genet, 2007, 39 (4): 534~539 ［26］ 't Hart L M, Hansen T, Rietveld I, et al. Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. Diabetes, 2005, 54 (6):1892~1895 ［27］ 朱斌,王恩多. 氨基酰tRNA 合成酶与神经退行性疾病. 生物化学与生物物理进展, 2007, 34(6): 562~566 Zhu B,Wang E D. Neurodegenerationrelated AminoacyltRNA Synthetases. Progress in Biochemistry and Biophysics, 2007, 34(6): 562~566